Optimizing the screening process for TIRADS could reduce the number of unnecessary thyroid biopsies
Conspicuous disparities exist in biopsy guidelines among TIRADS systems, urging increased caution among healthcare providers, particularly when they are extensively applied in patient evaluations. As evidently demonstrated by our research findings, combining recommendations from two TIRADS systems could effectively and safely lessen UBRs. These findings also advocate for the integration of prognostic-impact assessment in developing novel biopsy optimization strategies.
Authors
- Ke Lu (ORCID: https://orcid.org/0000-0003-0650-4210)
- Kehong Gan
- Chunwang Huang (ORCID: https://orcid.org/0000-0003-2152-5298)
- Jian Kuang (ORCID: https://orcid.org/0000-0001-5166-477X)
- Shuiqing Lai (ORCID: https://orcid.org/0000-0002-5352-7805)
- Zhijiang Chen (ORCID: https://orcid.org/0000-0002-2546-7075)
- Xiaoyan Chen (ORCID: https://orcid.org/0000-0001-8109-4691)
- Long Wang (ORCID: https://orcid.org/0000-0002-6247-9550)
- Shuzhen Cong
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1530/ec-25-0097
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00